Inside of a study in breast cancer cells, The mix of lapatinib, a twin HER2/neu and EGFR tyrosine kinase inhibitor, with INK128 prevented each HER2 and HER3 phosphorylation induced by INK128 and created synergistic induction of cell death in different HER2-good cell strains immune to trastuzumab and lapatinib. In vivo https://johnt641jot5.vidublog.com/profile